Wells Fargo & Company Cabaletta Bio, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,162 shares of CABA stock, worth $55,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,162

Previous 19,309 25.13%

Holding current value

$55,330

Previous $144,000 20.83%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.94 - $8.24 $19,120 - $39,988	4,853 Added 25.13%	24,162 $114,000
Q2 2024 Aug 13, 2024	BUY	$7.22 - $18.82 $42,843 - $111,677	5,934 Added 44.37%	19,309 $144,000
Q1 2024 May 10, 2024	SELL	$16.79 - $25.38 $11,467 - $17,334	-683 Reduced 4.86%	13,375 $228,000
Q4 2023 Feb 09, 2024	SELL	$12.21 - $23.36 $207,386 - $396,769	-16,985 Reduced 54.71%	14,058 $319,000
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $204,914 - $322,775	17,307 Added 126.0%	31,043 $472,000
Q2 2023 Aug 15, 2023	BUY	$7.65 - $13.95 $89,374 - $162,977	11,683 Added 569.07%	13,736 $177,000
Q1 2023 May 12, 2023	BUY	$7.08 - $12.62 $5,203 - $9,275	735 Added 55.77%	2,053 $16,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $9.3 $1,597 - $23,212	-2,496 Reduced 65.44%	1,318 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $20 - $65	32 Added 0.85%	3,814 $2,000
Q2 2022 Aug 12, 2022	BUY	$0.99 - $2.11 $117 - $251	119 Added 3.25%	3,782 $4,000
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $19,768 - $46,126	-11,767 Reduced 76.26%	3,663 $7,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $25,381 - $110,590	-7,554 Reduced 32.87%	15,430 $58,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $868 - $1,550	124 Added 0.54%	22,984 $280,000
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $17,503 - $28,515	-2,431 Reduced 9.61%	22,860 $197,000
Q1 2021 May 13, 2021	SELL	$10.39 - $14.53 $267,989 - $374,772	-25,793 Reduced 50.49%	25,291 $280,000
Q4 2020 Feb 09, 2021	BUY	$9.81 - $15.8 $155,723 - $250,809	15,874 Added 45.08%	51,084 $637,000
Q3 2020 Nov 05, 2020	SELL	$9.71 - $14.41 $478,295 - $709,807	-49,258 Reduced 58.32%	35,210 $382,000
Q2 2020 Aug 13, 2020	BUY	$6.39 - $11.28 $487,946 - $861,352	76,361 Added 941.91%	84,468 $941,000
Q1 2020 May 14, 2020	BUY	$6.0 - $18.67 $48,642 - $151,357	8,107 New	8,107 $59,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cabaletta Bio, Inc. Transaction History